Candidate gene study of genetic thrombophilic polymorphisms in pre-eclampsia and recurrent pregnancy loss in Sinhalese women

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 9, 2012, Pages 1168-1176

  Dissanayake, Vajira H W ^a   Sirisena, Nirmala D ^a   Weerasekera, Lakshini Y ^a,b   Gammulla, Chumithri G ^a,c   Seneviratne, Harshalal R ^a   Jayasekara, Rohan W ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

Author keywords

Genetics; Hematologic and clotting; Molecular genetics; Pre eclampsia; Recurrent pregnancy loss

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; RECURRENT ABORTION; SRI LANKA; THROMBOPHILIA;

ABORTION, HABITUAL; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; SRI LANKA; THROMBOPHILIA; YOUNG ADULT;

EID: 84869188617     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2012.01846.x     Document Type: Article

References (29)

1. Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod 2002; 17: 1633-1637. (Pubitemid 34661820)
2. Kupferminc M, Eldor A, Steinman N et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13. (Pubitemid 29024678)
3. Kupferminc M, Fait G, Many A, Gordon D, Eldor A, Lessing J. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000; 96: 45-49. (Pubitemid 30336278)
4. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999; 82: 6-9. (Pubitemid 29368764)
5. Li TC, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: Aetiology, management and prognosis. Hum Reprod Update 2002; 8: 463-481. (Pubitemid 35175207)
6. Coulam C, Jeyendran R, Fishel L, Roussev R. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol 2006; 55: 360-368.
7. Grandone E, Margaglione M, Colaizzo D et al. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997; 77: 822-824. (Pubitemid 27239097)
8. Vossen C, Preston F, Conard J et al. Hereditary thrombophilia and fetal loss: A prospective follow-up study. J Thromb Haemost 2004; 2: 592-596. (Pubitemid 40185682)
9. Rai R, Shlebak A, CohenHet al. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod 2001; 16: 961-965. (Pubitemid 32451834)
10. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002; 101: 6-14. (Pubitemid 34142238)
11. Frosst P, Blom H, Milos R et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
12. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64: 169-172. (Pubitemid 28453294)
13. Poort S, Rosendaal F, Reitsma P, Bertina R. A common genetic variation in the 3?-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703. (Pubitemid 26383091)
14. Bertina R, Koeleman B, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67. (Pubitemid 24144355)
15. Lunghj B, Iacaviella L, Gemmati D et al. Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma. Thromb Haemost 1996; 75: 45-48. (Pubitemid 26051193)
16. Dissanayake V, Weerasekera L, Gammulla G, Jayasekara R. Prevalence of genetic thrombophilic polymorphisms in the Sri Lankan population - implications for association study design and clinical genetic testing services. Exp Mol Pathol 2009; 87: 159-162.
17. Dissanayake V, Morgan L, Broughton Pipkin F. The urine protein heat coagulation test - a useful screening test for proteinuria in pregnancy in developing countries: A method validation study. BJOG 2004; 111: 491-494. (Pubitemid 38621882)
18. Dissanayake VH, Samarasinghe HD, Morgan L, Jayasekara RW, Seneviratne HR, Broughton Pipkin F Morbidity and mortality associated with pre-eclampsia at two tertiary care hospitals in Sri Lanka. J Obstet Gynaecol Res 2007; 33: 56-62. (Pubitemid 46025394)
19. Beauchamp N, Daly M, Hampto K, Cooper P, Preston E, Peake I. High prevalence of a mutation in the factor V gene within the UK population: Relationship to activated protein C resistance and familial thrombosis. Br J Haematol 1994; 88: 219-222. (Pubitemid 24293881)
20. Dudbridge F. Methods and software for association tests of uncertain haplotypes in case-parent trios. Am J Hum Gene 2002; 71 (Suppl): A: 2338.
21. Gauderman W. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 2002; 155: 478-484. (Pubitemid 34174160)
22. Finan R, Tamim H, Ameen G, Sharida H, Rashid M. Prevalence of factor V G1691A (Factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol 2002; 71: 300-305. (Pubitemid 35396947)
23. The GOPEC Consortium. Disentangling fetal and maternal susceptibility for pre-eclampsia: A British multicenter candidate-gene study. Am J Hum Genet 2005; 77: 127-131.
24. Said JBS, Moses E, Walker S, Borg A, Higgins J. Ethnic differences in the prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian prenatal population. Hum Biol 2006; 78: 403-412. (Pubitemid 46106352)
25. Aggarwal S, Dimri N, Tandon I, Agarwal S. Preeclampsia in North Indian women: The contribution of genetic polymorphisms. J Obstet Gynaecol Res 2011; 37: 1335-1341.
26. Omar S, Qvist R, Khaing S, Muniandy S, Bhalla S. Thrombophilic mutations in pre-eclampsia and pregnancy-induced hypertension. J Obstet Gynaecol Res 2008; 34: 174-178. (Pubitemid 351537732)
27. Biswas A, Choudhry P, Mittal A et al. Recurrent abortions in Asian Indians: No role of factor V Leiden Hong Kong/ Cambridge mutation and MTHFR polymorphism. Clin Appl Thromb Hemost 2008; 14: 102-104.
28. Vora S, Shetty S, Salvi V, Satoskar P, Ghosh K. Thrombophilia and unexplained pregnancy loss in Indian patients. Natl Med J India 2008; 21: 116-119.
29. Hidellage N, Goonasekera H, Jayasekara R, Wijesundara W, Dissanayake V. Factor 5 Hong Kong and Cambridge mutations are absent in patients with deep vein thrombosis. Ceylon Med J 2011; 56 (Suppl 1): 32.